REBUS Medinvest A/S — Credit Rating and Financial Key Figures

REBUS Medinvest A/S (CVR number: 33874057) is a company from HORSENS. The company recorded a gross profit of 44.1 mDKK in 2025. The operating profit was 30 mDKK, while net earnings were 45 mDKK. The profitability of the company measured by Return on Assets (ROA) was 3.7 %, which can be considered weak but Return on Equity (ROE) was 7.6 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 57.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. REBUS Medinvest A/S's liquidity measured by quick ratio was 9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.